YOUNGHEARTVALVE INC
Next-generation polymeric TAVR technology inspired by nature
WILMINGTON, United States · Founded 2021 · $2.8M raised
- Headquarters
- WILMINGTON, Delaware
- Employees
- 1–10
- Founded
- 2021
- Business Model
- B2B
- Website
- youngheartvalve.com
- Total Funding
- $2.8M
- Last Round
- $2.8M GrantOct 2024
- Rounds
- 1
About
YoungHeartValve is a medical device company developing a next-generation polymeric transcatheter aortic valve (TAVR) that integrates hyaluronan into polymer leaflets to resist thrombosis and calcification without animal-derived tissue. Their fully synthetic, tissue-free valve platform enables scalable, automated manufacturing and has demonstrated biocompatibility in pre-clinical animal studies. The company has received NIH SBIR grants and holds multiple patents.
Summary
YOUNGHEARTVALVE INC is a Biotech company based in WILMINGTON, United States, founded in 2021. It has raised $2.8M in total across 1 round, most recently a $2.8M Grant round in Oct 2024. Investors include NIH.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2024
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform

Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.